Literature DB >> 8696342

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.

N Rahman1, L Arbour, P Tonin, J Renshaw, J Pelletier, S Baruchel, K Pritchard-Jones, M R Stratton, S A Narod.   

Abstract

Wilms' tumour (WT) is one of the most common solid tumours of childhood, occurring in 1 in 10,000 children and accounting for 8% of childhood cancers. It is believed to result from malignant transformation of abnormally persistent renal stem cells (nephrogenic rests) which retain embryonic differentiation potential. Although WT is usually sporadic, approximately one percent occur in families in which susceptibility appears to be inherited as an autosomal dominant trait with incomplete penetrance. Predisposition to other cancers or to the developmental abnormalities associated with sporadic WT is not usually apparent in WT families. The WT1 gene at 11p13 (ref.2), and additional genes on chromosomes 11p15 (ref. 3) and 16q (ref. 4) have been implicated in the development of WT but are not responsible for familial WT. We have carried out a genome linkage search in a large Canadian family with seven confirmed cases of WT. Our results provide strong evidence for the localisation of a familial WT predisposition gene, FWT1, to an 18-centimorgan (cM) interval on chromosome 17q12-q21.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696342     DOI: 10.1038/ng0896-461

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  24 in total

1.  Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour.

Authors:  P R Hoban; R L Cowen; E L Mitchell; D G Evans; M Kelly; P J Howard; J Heighway
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.

Authors:  E Serra; S Puig; D Otero; A Gaona; H Kruyer; E Ars; X Estivill; C Lázaro
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.

Authors:  A K Charles; K W Brown; P J Berry
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.

Authors:  S Hing; Y J Lu; B Summersgill; L King-Underwood; J Nicholson; P Grundy; R Grundy; M Gessler; J Shipley; K Pritchard-Jones
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.

Authors:  Gulden Diniz; Safiye Aktas; Aysen Turedi; Gunyuz Temir; Ragip Ortac; Canan Vergin
Journal:  Tumour Biol       Date:  2011-05-08

Review 6.  Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice.

Authors:  R H Scott; L Walker; Ø E Olsen; G Levitt; I Kenney; E Maher; C M Owens; K Pritchard-Jones; A Craft; N Rahman
Journal:  Arch Dis Child       Date:  2006-07-20       Impact factor: 3.791

Review 7.  Genetics of pediatric renal tumors.

Authors:  Brigitte Royer-Pokora
Journal:  Pediatr Nephrol       Date:  2012-03-30       Impact factor: 3.714

Review 8.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

9.  A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.

Authors:  Fatemeh Abbaszadeh; Karen T Barker; Carmel McConville; Richard H Scott; Nazneen Rahman
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

10.  Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.

Authors:  Timothy Blake Palculict; E Cristy Ruteshouser; Yu Fan; Wenyi Wang; Louise Strong; Vicki Huff
Journal:  J Med Genet       Date:  2015-11-13       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.